Incentives

AMR stays on the G20’s to-do list with calls for Push and Pull mechanisms

Aside: Please look closely at the forward calendar. In addition to two new webinars from GARDP’s REVIVE project, there is a meeting in Thailand in December that focuses on alternatives to antibiotics. I’m told that the program is primarily focused on veterinary and agricultural uses, but previous year’s attendees have found the discussion to have broad application

Read More »

Why vaccines for AMR? What is their value? Grant opportunity for research on this topic / Great NPR TED Radio Hour on vaccines

Dear All:​First, and with a closing date of 12 Sep 2019, Wellcome Trust is offering grants of up to GBP 750k for research investigating the impact of vaccines on antibiotic use and/or antimicrobial resistance (go here for details). The core goal of this funding scheme is to develop data that would support and inform vaccine decision-makers around the world as they

Read More »

2020 US Federal Funding Bill boosts support for AMR

Dear All, On Friday, 20 Dec 2020, legislation was signed to fund the US government through Sep 2020. Relevant to AMR: The bill provides a $50 million increase in funding to NIAID for antimicrobial resistance. NIAID will also have to report to Congress on the success rate for these particular grants. The bill provides funding for

Read More »

Two research calls: FDA (rabbit VAP models) and JPIAMR (aquatic pollutants)

Dear All, Two important new research calls are now out. First, FDA is offering research funding of up to $1m to support creation of rabbit models of ventilator-associated bacterial pneumonia (VAP or VABP, depending on your preferred abbreviation) due to carbapenem-resistant strains of A. baumannii and P. aeruginosa. The call for proposals is via FDA Broad Agency Announcement (FDABAA-20-00123N, link), an ongoing

Read More »

UK NHS Antibiotic Subscription Pilot: Game (almost) on!

Dear All, 3 Apr 2020 update: Significant additional details on the pilot were shared via a 29 Mar 2020 webinar (link to newsletter) and then a FAQ document (link to newsletter). The game is definitely afoot! The hoofbeats of the cavalry bringing us the UK NHS antibiotic subscription model are definitely getting louder! As you

Read More »

WHO wants your input on its draft TPPs for needed antibacterial agents

Dear All, WHO has developed a set of draft TPPs (target product profiles) for needed new antibiotics. As part of the process, they are now opening a public consultation. Here is the essential text from their announcement: “The World Health organization (WHO) is developing target products profiles (TPPs) for needed antibacterial agents, providing the public

Read More »

NIAID to fund a Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)

Dear All, Warm up your chemistry set! NIAID has just released a pre-solicitation notice of their intent to request applications for a new NIAID contract intended to establish an innovative Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). NIAID anticipates awarding a single CC4CARB contract funding 28,000 direct labor hours per year for up to 5 years. The core

Read More »
Scroll to Top